{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:25:54Z","timestamp":1788827154744,"version":"build-2803163510"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1097\/olq.0b013e31820bc880","type":"journal-article","created":{"date-parts":[[2011,2,11]],"date-time":"2011-02-11T03:17:04Z","timestamp":1297394224000},"page":"622-629","source":"Crossref","is-referenced-by-count":45,"title":["Prevalence of Human Papillomavirus Antibodies in Males and Females in England"],"prefix":"10.1097","volume":"38","author":[{"given":"Sarika","family":"Desai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Jit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Nichols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ray","family":"Borrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Wilding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Linford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine M.","family":"Lowndes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Nardone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Pebody","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Soldan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20210213","doi-asserted-by":"crossref","first-page":"S3\/26","DOI":"10.1016\/j.vaccine.2006.05.026","article-title":"Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases.","volume":"24","author":"Clifford","year":"2006","journal-title":"Vaccine"},{"key":"R2-8-20210213","doi-asserted-by":"crossref","first-page":"S3\/11","DOI":"10.1016\/j.vaccine.2006.05.111","article-title":"Chapter 2: The burden of HPV-related cancers.","volume":"24","author":"Parkin","year":"2006","journal-title":"Vaccine"},{"key":"R3-8-20210213","doi-asserted-by":"crossref","first-page":"S3\/35","DOI":"10.1016\/j.vaccine.2006.06.015","article-title":"Chapter 4: Burden and management of non-cancerous HPV-related conditions: HPV-6\/11 disease.","volume":"24","author":"Lacey","year":"2006","journal-title":"Vaccine"},{"key":"R5-8-20210213","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/sj.bjc.6603210","article-title":"HPV testing in routine cervical screening: Cross sectional data from the ARTISTIC trial.","volume":"95","author":"Kitchener","year":"2006","journal-title":"Br J Cancer"},{"key":"R6-8-20210213","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1136\/jcp.57.1.68","article-title":"Multiple high risk HPV infections are common in cervical neoplasia and young women in a cervical screening population.","volume":"57","author":"Cuschieri","year":"2004","journal-title":"J Clin Pathol"},{"key":"R7-8-20210213","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1038\/sj.bjc.6604324","article-title":"ARTISTIC Study Group. Prevalence of type-specific HPV infection by age and grade of cervical cytology: Data from the ARTISTIC trial.","volume":"98","author":"Sargent","year":"2008","journal-title":"Br J Cancer"},{"key":"R8-8-20210213","doi-asserted-by":"crossref","first-page":"S3\/42","DOI":"10.1016\/j.vaccine.2006.06.018","article-title":"Chapter 5: Updating the natural history of HPV and anogenital cancer.","volume":"24","author":"Moscicki","year":"2006","journal-title":"Vaccine"},{"key":"R9-8-20210213","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1086\/315498","article-title":"Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection.","volume":"181","author":"Carter","year":"2000","journal-title":"J Infect Dis"},{"key":"R10-8-20210213","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1086\/604729","article-title":"Seroprevalence of human papillomavirus types 6, 11, 16 and 18 in the United States: National health and nutrition examination survey 2003\u20132004.","volume":"200","author":"Markowitz","year":"2009","journal-title":"J Infect Dis"},{"key":"R11-8-20210213","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1086\/587895","article-title":"Population seroprevalence of human papillomavirus types 6, 11, 16, and 18 in men, women and children in Australia.","volume":"46","author":"Newall","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R12-8-20210213","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jcv.2006.12.004","article-title":"Seroprevalence of human papillomavirus types 16 and 18 in the general population in Taiwan: Implication for optimal age of human papillomavirus vaccination.","volume":"38","author":"Chen","year":"2007","journal-title":"J Clin Virol"},{"key":"R13-8-20210213","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/sj.bjc.6603955","article-title":"Prevalence of human papillomavirus antibodies in young females subjects in England.","volume":"97","author":"Jit","year":"2007","journal-title":"Br J Cancer"},{"key":"R14-8-20210213","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/ije\/29.2.362","article-title":"Ten years of serological surveillance in England and Wales: Methods, results, implications and action.","volume":"29","author":"Osborne","year":"2000","journal-title":"Int J Epidemiol"},{"key":"R15-8-20210213","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1128\/CDLI.10.1.108-115.2003","article-title":"Simultaneous quantitation of antibodies to neutralizing epitopes on virus-like particles for human papillomavirus types 6, 11, 16, and 18 by a multiplexed luminex assay.","volume":"10","author":"Opalka","year":"2003","journal-title":"Clin Diagn Lab Immunol"},{"key":"R16-8-20210213","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1128\/CDLI.12.8.959-969.2005","article-title":"Optimization and validation of a multiplexed luminex assay to quantify antibodies to neutralizing epitopes on human papillomarivuses 6, 11, 16 and 18.","volume":"12","author":"Dias","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"key":"R17-8-20210213","doi-asserted-by":"crossref","DOI":"10.4159\/harvard.9780674428928","article-title":"Catalytic Models in Epidemiology.","author":"Muench","year":"1959"},{"key":"R18-8-20210213","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1177\/0272989X09336140","article-title":"Estimating progression rates for human papillomavirus infection from epidemiological data.","volume":"30","author":"Jit","year":"2010","journal-title":"Med Decis Making"},{"key":"R19-8-20210213","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/S0140-6736(01)06885-4","article-title":"Sexual behaviour in Britain: Early heterosexual experience.","volume":"358","author":"Wellings","year":"2001","journal-title":"Lancet"},{"key":"R20-8-20210213","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1109\/TAC.1974.1100705","article-title":"A new look at the statistical model identification.","volume":"19","author":"Akaike","year":"1974","journal-title":"IEEE Trans Automat Contr"},{"key":"R21-8-20210213","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1086\/507432","article-title":"Prevalence of HPV infection among men: A systematic review of the literature.","volume":"194","author":"Dunne","year":"2006","journal-title":"J Infect Dis"},{"key":"R22-8-20210213","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/01.OLQ.0000118425.49522.2C","article-title":"Gender differences in sexual biomarkers and behaviors associated with human papillomavirus -16, -18 and -33 seroprevalence.","volume":"31","author":"Kreimer","year":"2004","journal-title":"Sex Transm Dis"},{"key":"R23-8-20210213","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1097\/OLQ.0b013e3181bc094b","article-title":"HPV 6\/11, 16, 18 seroprevalence in men in two US cities.","volume":"36","author":"Dunne","year":"2009","journal-title":"Sex Transm Dis"},{"key":"R24-8-20210213","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/sj.bjc.6605747","article-title":"Multi-site study of HPV type-specific prevalence in women with cervical cancer, intraepithelial neoplasia and normal cytology, in England.","volume":"103","author":"Howell-Jones","year":"2010","journal-title":"Br J Cancer"},{"key":"R25-8-20210213","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1006\/scbi.1999.0146","article-title":"The serological response to papillomaviruses.","volume":"9","author":"Dillner","year":"1999","journal-title":"Semin Cancer Biol"},{"key":"R26-8-20210213","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1086\/516505","article-title":"Seroreactivity to human papillomavirus type 16 virus-like particles is lower in high-risk men than in high-risk women.","volume":"176","author":"Svare","year":"1997","journal-title":"J Infect Dis"},{"key":"R28-8-20210213","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1258\/095646206780070992","article-title":"Surveillance of sexually transmitted diseases in general practice: A description of trends in the Royal College of General Practitioners Weekly Returns Service between 1994 and 2001.","volume":"17","author":"Simms","year":"2006","journal-title":"Int J STD AIDS"},{"key":"R29-8-20210213","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1086\/591095","article-title":"Age-specific prevalence, incidence, and duration of human papillomavirus infections in a cohort of 290 US men.","volume":"198","author":"Guiliano","year":"2008","journal-title":"J Infect Dis"},{"key":"R30-8-20210213","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1158\/1055-9965.EPI-04-0754","article-title":"Acquisition and persistence of human papillomavirus infection in younger men: A prospective follow-up study among Danish soldiers.","volume":"14","author":"Kjaer","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R31-8-20210213","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1086\/423817","article-title":"Seroepidemiology of infection with human papillomavirus 16 in men and women attending sexually transmitted disease clinics in the United States.","volume":"190","author":"Thompson","year":"2004","journal-title":"J Infect Dis"},{"key":"R32-8-20210213","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/sj.bjc.6601272","article-title":"Seroprevalence of human papillomavris-16, -18, -31 and -45 in a population-based cohort of 10 000 women in Costa Rica.","volume":"89","author":"Wang","year":"2003","journal-title":"Br J Cancer"},{"key":"R34-8-20210213","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/(SICI)1097-0215(19980504)76:3<341::AID-IJC10>3.0.CO;2-E","article-title":"Trends in seroprevalence of human papillomavirus type 16 among pregnant women in Stockholm, Sweden, during 1969\u20131989.","volume":"76","author":"af Geijersstam","year":"1998","journal-title":"Int J Cancer"},{"key":"R35-8-20210213","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1136\/sti.78.1.26","article-title":"The accuracy of reported sensitive sexual behaviour in Britain: Exploring the extent of change 1990\u20132000.","volume":"78","author":"Copas","year":"2002","journal-title":"Sex Transm Infect"}],"container-title":["Sexually Transmitted Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00007435-201107000-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:49:36Z","timestamp":1786042176000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00007435-201107000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/olq.0b013e31820bc880","relation":{},"ISSN":["0148-5717"],"issn-type":[{"value":"0148-5717","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}